50th Anniversary of the Pompidou Group5/1/2021
This year we will celebrate the 50th Anniversary of the Pompidou Group. Created in August 1971 - on the initiative of the then French President - as a European cooperation framework to fight against drug abuse and drug traficking, it has developed over the years into an international group which promotes a humanistic approach of drug policies, in line with the values of the Council of Europe. It grew from 7 founding states to 41 members today, including 3 non-European countries.
New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic4/1/2021
In this update from the the EU Early Warning System aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency’s early warning and risk-assessment activities. The report covers the period until October 2020 and this year focuses on global markets, glocal threats and the COVID-19 pandemic.
Download as PDF
Alcohol pricing in the WHO European Region: update report on the evidence and recommended policy actions 30/6/2020
This report summarizes the current evidence base for alcohol pricing policies and considers how this compares to current policies in place across the World Health Organization (WHO) European Region. Intended as a resource for governments and implementers, the report highlights challenges to effective pricing policies and provides recommendations for policy actions on alcohol pricing in the WHO European Region.
International Day against Drug Abuse and Illicit Trafficking (26 June)26/6/2020
“Drug policies must save lives and protect people, not stigmatise”, says João Castel-Branco Goulão on behalf of the Pompidou Group’s Portuguese Presidency, to mark the International Day against Drug Abuse and Illicit Trafficking (26 June).
“As new infections with COVID-19 are massively increasing worldwide and the crisis starts affecting all dimensions of our society, it is usually the most vulnerable, stigmatised and underserved who suffer the most: among them people who use drugs. Decision-makers need to support life-saving services for drug users so that they can respond to the crisis in a flexible and informed way. That's why the Pompidou Group has created an online platform where frontline workers can share and discuss their ideas and actions on how best to contain the spread of COVID-19 and prevent harm to people who use drugs and those in contact with them. In a period of crisis, more than ever, human rights must remain at the forefront of our drug policies,” he explains.
Over the last 40 years, the Pompidou Group has been the voice of the Council of Europe on drug issues. In a changing international environment, it remained firm on promoting a balanced approach between the necessity to address drug addiction and fight drug trafficking, and the responsibility of states to protect the health and human rights of people living within their territories. With the recent accessions of Armenia and Georgia, the Pompidou Group now has 41 member states, and its activities have extended even further on our continent.
Lisbon Addictions 2022: new date3/6/2020
Due to the current situation regarding the COVID-19 pandemic, the Lisbon Addictions programme committee has decided to postpone our next conference to 23-25 November 2022 in order to create an experience that is safe and rewarding for all involved.
Stay tuned for more news as we prepare to take things online in 2021 and to another level with a new type of event in 2022.
Save the date and let's stay connected!
Technical Report: Drug-related infectious diseases in Europe21/5/2020
EMCDDA just published latest update on drug-related infectious diseases in Europe among people who inject drugs. Released during European Testing Week, the report stresses that early diagnosis through testing, and improving links to treatment and care, are crucial steps towards reaching global health goals.
Read the news item:https://www.emcdda.europa.eu/…/testing-drug-related-infecti…
Lisbon Fast-Track Cities 202021/1/2020
Fast-Track Cities 2020 will be the second international gathering of more than 300 cities that are accelerating their responses to HIV, tuberculosis, and viral hepatitis – three diseases cited as urban health priorities in the New Urban Agenda as well as the Paris Declaration on Fast-Track Cities.
Organized by the International Association of Providers of AIDS Care (IAPAC), in collaboration with the Joint United Nations Programme on HIV/AIDS (UNAIDS) and other partners, the conference will take place September 7-10, 2020, in Lisbon, Portugal.
The conference’s aim is to highlight successes achieved across the Fast-Track Cities network, address cross-cutting challenges faced by local stakeholders, and share best practices in accelerating urban AIDS responses, inclusive of co-infectious diseases and co-morbid conditions, including those associated with aging with HIV.
The conference will include two half-days of pre-conference events followed by two and a half days of conference featuring plenary sessions, panel discussions, skills-building workshops, oral abstract presentations, and e-poster sessions.
For more information https://www.iapac.org/
Press Release: Lisbon Addictions 201915/10/2019
European Drug Report 20196/6/2019
Just published, in 24 languages analysis of the latest data on the drug situation and responses to it: European Drug Report: Trends and Developments
Lisbon Addictions 2019 - Register and submit abstracts 23/10/2018
Leading international experts in the field of addiction science will meet in Lisbon from
23–25 October 2019 for the Third European conference on addictive behaviours and dependencies. The theme of the conference is ‘The future of addictions: new frontiers for policy, practice and science’. Registration and a call for abstracts open today.
Abstracts may be submitted until 31 January 2019 on www.lisbonaddictions.eu on the following themes:
· Futures: identifying and meeting emerging needs; prediction, preparedness, innovations and new challenges;
· Better practice: improving how we respond; supporting the development and implementation of more effective prevention, treatment, and harm reduction interventions;
· Better science: aetiology, basic science, neuroscience and pre-clinical studies;
· Better methods: epidemiology, monitoring estimates and models;
· Better society: overcoming barriers, effective policies, regulations and laws; culture and context.
Over 1 000 participants are expected at the conference, which will provide a unique networking opportunity for researchers, practitioners and policy experts across countries and disciplines. It will also address new challenges and developing fields and provide an occasion for early-stage researchers to enhance their careers.
Key deadlines: 31 January— abstracts; 28 February — Early-bird registration; 29 June— Regular registration.
Global status report on alcohol and health 201826/9/2018
21 September 2018 – Geneva. More than 3 million people died as a result of harmful use of alcohol in 2016, according a report released by the World Health Organization (WHO) today.
This represents 1 in 20 deaths. More than three quarters of these deaths were among men. Overall, the harmful use of alcohol causes more than 5% of the global disease burden.
available at: http://www.who.int/substance_abuse/publications/global_alcohol_report/en/
International Day Against Drug Abuse and Illicit Trafficking, 26 June 22/6/2018
By resolution 42/112 of 7 December 1987, the General Assembly decided to observe 26 June as the International Day against Drug Abuse and Illicit Trafficking as an expression of its determination to strengthen action and cooperation to achieve the goal of an international society free of drug abuse.
Supported each year by individuals, communities and various organizations all over the world, this global observance aims to raise awareness of the major problem that illicit drugs represent to society.
The outcome document
recommends measures to address demand and supply reduction, and to improve access to controlled medicines while preventing diversion. The recommendations also cover the areas of human rights, youth, children, women and communities; emerging challenges, including new psychoactive substances; strengthening international cooperation; and alternative development. The text puts new emphasis on proportionate national sentencing policies and practices for drug-related offences, and features a strong focus on prevention and treatment.
Project Mind your Trip19/6/2018
This online intervention offer provides anonymous, free-of-charge professional support to NPS-consuming youth by providing NPS-related information, a validated self-assessment test, an online diary, and three 30-day intervention modules (‘Brief Intervention’, Safer Use’, and ‘Quit or Reduce’). The intervention programme will be operated for (at least) the next 5 months by trained prevention experts, and is available in 10 languages (DE, FI, FR, GR, IT, LV, NL, PT, SI, SK) in 13 EU countries: Austria, Belgium, Cyprus, Finland, Germany, Greece, Italy, Latvia, Luxembourg, The Netherlands, Portugal, Slovakia, and Slovenia.
New developments in national drug strategies in Europe8/11/2017
This paper gives an overview of some recent developments in the tools most commonly used to manage national drug policies: strategies, coordination mechanisms and evaluations. It is based on an analysis of reports on national drug policies compiled by the EMCDDA’s Reitox focal points in the EMCDDA reporting countries (28 EU Member States, plus Turkey and Norway), consultation with experts and scientific literature.
Table of contents
- Introduction — implementing and managing drug policies
- National drug strategies — broader scope and use
- National coordination mechanisms and drug strategies
- National drug strategy evaluation
- Conclusion — a widening strategic focus
Download a copy from: www.emcdda.europa.eu/publications
SICAD hosted a Georgian delegation 13/9/2017
On September 12, SICAD hosted a Georgian delegation consisting of members of Parliament, Judicial Power and representatives of the civil society working in addictive behaviours and dependencies.
The meeting was marked by a very active participation of visitors who wanted to know all the scope and application of the Decriminalization Law, namely on what regards the number of users presented to the CDT (Commissions for the Dissuasion of Drug Abuse) and the available responses. The budgetary issue was also addressed in a cost/benefit perspective of the investment in the model implemented in Portugal.
During this visit, the delegation also had the opportunity to learn about harm reduction work and policies related to addictive behaviours and dependencies in our country.
The Georgian Parliament is currently discussing the adoption of a legislative initiative aimed at decriminalizing drug use, a proposal inspired by the Portuguese model, replicating all its strands. If this happens, it will be the first country in the world to do so.
European masters in Drug and Alcohol Studies24/7/2017
The ’Università del Piemonte Orientale (Novara - Italy) promotes the third edition of the European Master in Drugs and Alcohol Studies (EMDAS), together with the University of Aarhus (Denmark), Middlesex University, the University Miguel Hernandez de Elche (Alicante, Spain) and in collaboration with the EMCDDA in Lisbon.
The Master program aims to give to the students the opportunity to explore the theme of consumption and abuse of legal and illegal substances in an international and multi-disciplinary perspective. It will be an opportunity to address these complex issues in a comparative perspective with the possibility of a concrete exchange of knowledge between different experiences and contexts.
Please find attached the leaflet and the poster of the master. All the information will be at your disposal at www.emdas.it. The registration is still open until 31 August 2017.
JUST-2017-AG-DRUG: Supporting Initiatives in the Field of Drugs Policy21/7/2017
Types of action: JUST-DRUGS-AG HOME Action Grant
Publication date: 04 July 2017
Deadline: 25 October 2017 17:00:00
See more in: https://ec.europa.eu
Message of United Nations Secretary-General, António Guterres, on the International Day Against Drug Abuse and Illicit Trafficking 27/6/2017
Message of United Nations Secretary-General, António Guterres, on the International Day Against Drug Abuse and Illicit Trafficking
26 June 2017
Last year, at the UN General Assembly Special Session on the World Drug Problem (UNGASS), the international community took steps to mobilize a multifaceted, collective response to the full range of issues related to drug abuse and illicit trafficking. Governments came together to chart a new path forward that is more effective and humane, and leaves no one behind.
UNGASS was a ground-breaking moment that provided a detailed and forward-looking blueprint for action. Together, we must honour the unanimous commitments made to reduce drug abuse, illicit trafficking and the harm that drugs cause, and to ensure that our approach promotes equality, human rights, sustainable development, and greater peace and security.
I know from personal experience how an approach based on prevention and treatment can yield positive results. As Prime Minister of Portugal, I used the flexibility afforded by the three international drug control conventions to introduce non-criminal responses to the possession of drugs for personal use. Greater resources were allocated to prevention, treatment, and social reintegration programs, including harm reduction measures.
Portugal now has one of the lowest death rates for drug use in Europe. In 2001, Portugal had the highest rate of HIV amongst injecting drug users in the region; since the introduction of the new policy, this rate, and rates of all sexually transmitted diseases, have decreased dramatically. Overall drug use rates have also fallen.
I am proud of these results and hope this experience will contribute to the discussion and encourage Member States to continue exploring comprehensive and evidence-based solutions.
The UNGASS follow-up process provides us with an institutional framework to learn from each other and share best practices. It is vital that we examine the effectiveness of the War on Drugs approach, and its consequences for human rights.
Despite the risks and challenges inherent in tackling this global problem, I hope and believe we are on the right path, and that together we can implement a coordinated, balanced and comprehensive approach that leads to sustainable solutions.
This would be the best possible way to implement the UNGASS recommendations and to have a positive impact on the lives of millions of people around the world.
Just published : European Drug Report 20176/6/2017
BBC Wales interview João Goulão17/3/2017
Study: A review and assessment of EU drug policy3/3/2017
This study, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the drug policies in international fora, at EU level, in seven Member States and in three non-EU countries. The study highlights the very different approaches taken and their varying level of effectiveness.
New psychoactive substances in Europe: legislation and prosecution — current challenges and solutions16/11/2016
Eurojust, the European Union’s judicial cooperation unit, and the EMCDDA, have released their first joint publication entitled New psychoactive substances in Europe. Legislation and prosecution — current challenges and solutions.
The rapid evolution of the European market for new psychoactive substances (NPS) has challenged national authorities to find suitable and efficient responses to the public health and judicial problems caused by these substances. The legal issues surrounding the control of new substances are complex, and this publication examines different control mechanisms and their implications.
Publication available at:
European Drugs Summer School 201717/10/2016
From today on you can register for the European Drugs Summer School 2017
More about the fees and payment methods on the EDSS website:
Rarha - Final Conference12/10/2016
Lisbon, 13/14 outubro - Fundação Oriente
For more information, go to www.rarha.eu
SICAD hosted the 6th meeting of MedSPAD 27/9/2016
SICAD hosted the 6th meeting of MedSPAD Committee, which objective is to share experiences between countries of the MedNET Network of Group Pompidou of the Council of Europe who have conducted the MedSPAD or which to to do so. The added value of this Committee is is to discuss the findings of surveys and how they may be used for the design of drug and drug addiction prevention policies and their monitoring.
European School Survey Project on Alcohol and other Drugs - ESPAD 201514/9/2016
Date: 20 September 2016
The report will be available online at: www.espad.org
RARHA Policy Dialogue6/9/2016
Today, European policymakers will discuss the importance, relevance and implementation of policy and action to reduce alcohol related harm across Europe. They will participate in a policy dialogue in the framework of the European Joint Action on reducing alcohol related harm (RARHA). The policy dialogue, which is organised by EuroHealthNet, aims to provide new knowledge and tools based on RARHA outcomes in three areas in particular: (1) monitoring of drinking patterns and harm, (2) drinking guidelines, and (3) finding good practice examples and building a tool kit.
RARHA’s executive coordinator Manuel Cardoso from the General Directorate for Intervention on Additive Behaviours and Dependencies in Portugal said that “RARHA has contributed greatly to enhance knowledge about alcohol related harm in Europe and how to handle it. This event is a great opportunity to showcase this to European policymakers and urge them to strengthen their actions in this field.”
The work on ‘monitoring’ was twofold. On the one hand, partners developed the Standardised European Alcohol Survey (SEAS) instrument, which was implemented in 20 European countries and covers policy-relevant issues, like alcohol consumption, risky single occasion drinking, context of drinking, drinking problems with focus on harm from others, attitudes towards alcohol policy as well as unrecorded supply.
On the other hand, RARHA aimed to strengthen comparative alcohol survey methodology. Partners collected data from 24 surveys (2008-2012) from 17 countries and established a common database of over 300,000 records. Results show for example that over 20% of men and over 10% of women drink in a hazardous way at least once a month, and that over 40% to over 50% of respondents support alcohol control measures such as high prices, restrictions on number of outlets, time restrictions and advertising bans. The EU will gain genuine benefits if RARHA SEAS is regularly applied as a monitoring tool, offering the opportunity for monitoring trends in alcohol consumption and related harm as well as for tracing changes in attitudes towards alcohol policy.
Partners working on drinking guidelines looked at current specifications of low risk alcohol consumption across partner countries, on guidelines relating to drinking by young people, on brief intervention practices and on public understanding of the “standard drink” concept. They suggest adopting the lifetime risk of early death due to alcohol as a common metric and using a common criterion for defining low risk. The latter would increase transparency when setting guidelines and contribute towards a common minimum level of protection. While a common concept of low risk drinking is considered desirable among experts, population guidelines would be best formulated at national level, not least because effective communication needs to take into account prevailing drinking patterns and harms, existing perceptions of risk and gaps in knowledge and awareness.
Last but not least, RARHA partners looked for concrete examples of good practice approaches to reduce alcohol related harm across Europe. Good practice approaches exist but are not collectively evaluated and available for use by other European countries. This European-wide assessment of alcohol prevention interventions is a unique way to improve the quality of interventions in three areas: public awareness, school based interventions and early interventions. It is a first step towards exchanging and promoting the implementation of evidence-based interventions, and for professionals to benefit from existing theoretical and practical knowledge and experience. Partners prepared recommendations for good practice approaches as well as a toolkit.
Note to editors
The European Joint Action on reducing alcohol related harm (RARHA) ran between 2014 and 2016 and involved 32 associated and 29 collaborative partners from all EU countries in addition to Norway, Switzerland and Iceland. RARHA’s final conference will take place on 13-14 October in Lisbon. You can find more information here.
Alcohol continues to be the third leading cause globally for disease and premature death . In the EU, the direct costs through healthcare, crime, policing, accidents and productivity losses were €155 billion in 2010 .
Justice Programme 2014-202019/7/2016
European Drug Report 201617/5/2016
What are the latest trends in drug supply to Europe? What drugs are causing the most harm and concern today? What are the most recent developments in drug prevention, treatment and policy? These and other questions are explored on 31 May in our annual overview of the European drug situation.
Interview Request - Dr. João Castel-Branco Goulão - Inspired Citizen Media2/5/2016
OUR JOURNEY TO UNGASS - Video for the Closing of the 59th session of the CND31/3/2016
<iframe width="480" height="270" src="https://www.youtube.com/embed/t9kL_0TAO6k" frameborder="0" allowfullscreen></iframe>
UNODC: "Portugal is an example of...9/3/2016
"Portugal is an example of country that recently decided not to put drug users in jail. According to the International Narcotics Control Board. Portugal's "decriminalisation" of drug usage in 2001fals within the Convention parameters: drug possession is still prohibited but the sanctions fal underthe adninistrative law, not the criminal law.
World Drug Report 2009
New York 2009
Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs9/3/2016